医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Ascend Performance Materials Announces Price Increase for Intermediate Materials

2020年09月11日 AM01:01
このエントリーをはてなブックマークに追加


 

HOUSTON

Ascend Performance Materials announced today a price increase for intermediate materials.

The price increase takes effect immediately and includes the following terms:

Material

Price Increase

Terms

Hexamethylene Diamine (HMD)

$100/MT

  • As contracts allow
  • Non-contract business – price determined on an order-by-order basis

Adiponitrile (ADN)

$100/MT

  • As contracts allow
  • Non-contract business – price determined on an order-by-order basis

Acrylonitrile (AN)

$85/MT

  • As contracts allow
  • Non-contract business – price determined on an order-by-order basis

Adipic Acid (AA)

$80/MT

  • As contracts allow
  • Non-contract business – price determined on an order-by-order basis

Customers should contact their local sales representative for additional information.

About Ascend Performance Materials

Ascend Performance Materials makes high-performance materials for everyday essentials and new technologies. Our focus is on improving quality of life and inspiring a better tomorrow through innovation. Based in Houston, Texas, and with regional offices in Shanghai, Brussels and Detroit, we are a fully integrated material solutions provider with eight global manufacturing facilities in the United States, Europe and China. Our 2,600-person global workforce makes the plastics, fabrics, fibers and chemicals used to make safer vehicles, cleaner energy, better medical devices, smarter appliances and longer-lasting apparel and consumer goods. We are committed to safety, sustainability and the success of our customers and our communities.

Find out more about Ascend at www.ascendmaterials.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005789/en/

CONTACT

Alison Jahn at +1 713-210-9809, ajahn@ascendmaterials.com

同じカテゴリーの記事 

  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
  • ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report